Franklin Strategic Series-FRANKLIN BIOTECHNOLOGY DISCOVERY FUND

Unternehmen Aktie, %
Contineum Therapeutics, Inc. Contineum Therapeutics, Inc. 2.77
Context Therapeutics Inc. Context Therapeutics Inc. 1.65
Alto Neuroscience, Inc. Alto Neuroscience, Inc. 1.58
IN8bio, Inc. IN8bio, Inc. 1.53
EyePoint Pharmaceuticals, Inc. EyePoint Pharmaceuticals, Inc. 1.5
HilleVax, Inc. HilleVax, Inc. 1.38
Oruka Therapeutics, Inc. Oruka Therapeutics, Inc. 0.95
Artiva Biotherapeutics, Inc. Artiva Biotherapeutics, Inc. 0.79
enGene Holdings Inc. enGene Holdings Inc. 0.7
Merus N.V. Merus N.V. 0.66
Satellos Bioscience Inc. 0.63
Kyverna Therapeutics, Inc. Kyverna Therapeutics, Inc. 0.57
ABIVAX Société Anonyme ABIVAX Société Anonyme 0.29

Kategorie Menge
Healthcare 9